Cargando…
Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD
BACKGROUND: Macrophages have been implicated in the pathogenesis of COPD. M1 and M2 macrophages constitute subpopulations displaying pro- and anti-inflammatory properties. We hypothesized that smoking cessation affects macrophage heterogeneity in the lung of patients with COPD. Our aim was to study...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072953/ https://www.ncbi.nlm.nih.gov/pubmed/21426578 http://dx.doi.org/10.1186/1465-9921-12-34 |
_version_ | 1782201596912861184 |
---|---|
author | Kunz, Lisette IZ Lapperre, Thérèse S Snoeck-Stroband, Jiska B Budulac, Simona E Timens, Wim van Wijngaarden, Simone Schrumpf, Jasmijn A Rabe, Klaus F Postma, Dirkje S Sterk, Peter J Hiemstra, Pieter S |
author_facet | Kunz, Lisette IZ Lapperre, Thérèse S Snoeck-Stroband, Jiska B Budulac, Simona E Timens, Wim van Wijngaarden, Simone Schrumpf, Jasmijn A Rabe, Klaus F Postma, Dirkje S Sterk, Peter J Hiemstra, Pieter S |
author_sort | Kunz, Lisette IZ |
collection | PubMed |
description | BACKGROUND: Macrophages have been implicated in the pathogenesis of COPD. M1 and M2 macrophages constitute subpopulations displaying pro- and anti-inflammatory properties. We hypothesized that smoking cessation affects macrophage heterogeneity in the lung of patients with COPD. Our aim was to study macrophage heterogeneity using the M2-marker CD163 and selected pro- and anti-inflammatory mediators in bronchoalveolar lavage (BAL) fluid and induced sputum from current smokers and ex-smokers with COPD. METHODS: 114 COPD patients (72 current smokers; 42 ex-smokers, median smoking cessation 3.5 years) were studied cross-sectionally and underwent sputum induction (M/F 99/15, age 62 ± 8 [mean ± SD] years, 42 (31-55) [median (range)] packyears, post-bronchodilator FEV(1 )63 ± 9% predicted, no steroids past 6 months). BAL was collected from 71 patients. CD163(+ )macrophages were quantified in BAL and sputum cytospins. Pro- and anti-inflammatory mediators were measured in BAL and sputum supernatants. RESULTS: Ex-smokers with COPD had a higher percentage, but lower number of CD163(+ )macrophages in BAL than current smokers (83.5% and 68.0%, p = 0.04; 5.6 and 20.1 ×10(4)/ml, p = 0.001 respectively). The percentage CD163(+ )M2 macrophages was higher in BAL compared to sputum (74.0% and 30.3%, p < 0.001). BAL M-CSF levels were higher in smokers than ex-smokers (571 pg/ml and 150 pg/ml, p = 0.001) and correlated with the number of CD163(+ )BAL macrophages (Rs = 0.38, p = 0.003). No significant differences were found between smokers and ex-smokers in the levels of pro-inflammatory (IL-6 and IL-8), and anti-inflammatory (elafin, and Secretory Leukocyte Protease Inhibitor [SLPI]) mediators in BAL and sputum. CONCLUSIONS: Our data suggest that smoking cessation partially changes the macrophage polarization in vivo in the periphery of the lung towards an anti-inflammatory phenotype, which is not accompanied by a decrease in inflammatory parameters. |
format | Text |
id | pubmed-3072953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30729532011-04-09 Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD Kunz, Lisette IZ Lapperre, Thérèse S Snoeck-Stroband, Jiska B Budulac, Simona E Timens, Wim van Wijngaarden, Simone Schrumpf, Jasmijn A Rabe, Klaus F Postma, Dirkje S Sterk, Peter J Hiemstra, Pieter S Respir Res Research BACKGROUND: Macrophages have been implicated in the pathogenesis of COPD. M1 and M2 macrophages constitute subpopulations displaying pro- and anti-inflammatory properties. We hypothesized that smoking cessation affects macrophage heterogeneity in the lung of patients with COPD. Our aim was to study macrophage heterogeneity using the M2-marker CD163 and selected pro- and anti-inflammatory mediators in bronchoalveolar lavage (BAL) fluid and induced sputum from current smokers and ex-smokers with COPD. METHODS: 114 COPD patients (72 current smokers; 42 ex-smokers, median smoking cessation 3.5 years) were studied cross-sectionally and underwent sputum induction (M/F 99/15, age 62 ± 8 [mean ± SD] years, 42 (31-55) [median (range)] packyears, post-bronchodilator FEV(1 )63 ± 9% predicted, no steroids past 6 months). BAL was collected from 71 patients. CD163(+ )macrophages were quantified in BAL and sputum cytospins. Pro- and anti-inflammatory mediators were measured in BAL and sputum supernatants. RESULTS: Ex-smokers with COPD had a higher percentage, but lower number of CD163(+ )macrophages in BAL than current smokers (83.5% and 68.0%, p = 0.04; 5.6 and 20.1 ×10(4)/ml, p = 0.001 respectively). The percentage CD163(+ )M2 macrophages was higher in BAL compared to sputum (74.0% and 30.3%, p < 0.001). BAL M-CSF levels were higher in smokers than ex-smokers (571 pg/ml and 150 pg/ml, p = 0.001) and correlated with the number of CD163(+ )BAL macrophages (Rs = 0.38, p = 0.003). No significant differences were found between smokers and ex-smokers in the levels of pro-inflammatory (IL-6 and IL-8), and anti-inflammatory (elafin, and Secretory Leukocyte Protease Inhibitor [SLPI]) mediators in BAL and sputum. CONCLUSIONS: Our data suggest that smoking cessation partially changes the macrophage polarization in vivo in the periphery of the lung towards an anti-inflammatory phenotype, which is not accompanied by a decrease in inflammatory parameters. BioMed Central 2011 2011-03-22 /pmc/articles/PMC3072953/ /pubmed/21426578 http://dx.doi.org/10.1186/1465-9921-12-34 Text en Copyright ©2011 Kunz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Kunz, Lisette IZ Lapperre, Thérèse S Snoeck-Stroband, Jiska B Budulac, Simona E Timens, Wim van Wijngaarden, Simone Schrumpf, Jasmijn A Rabe, Klaus F Postma, Dirkje S Sterk, Peter J Hiemstra, Pieter S Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD |
title | Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD |
title_full | Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD |
title_fullStr | Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD |
title_full_unstemmed | Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD |
title_short | Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD |
title_sort | smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in copd |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072953/ https://www.ncbi.nlm.nih.gov/pubmed/21426578 http://dx.doi.org/10.1186/1465-9921-12-34 |
work_keys_str_mv | AT kunzlisetteiz smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd AT lapperrethereses smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd AT snoeckstrobandjiskab smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd AT budulacsimonae smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd AT timenswim smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd AT vanwijngaardensimone smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd AT schrumpfjasmijna smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd AT rabeklausf smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd AT postmadirkjes smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd AT sterkpeterj smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd AT hiemstrapieters smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd AT smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd |